REZIPRES
- Product NDC
- 39822-1410
- 11-digit product format
- 398221410
- Labeler code
- 39822
- Product ID
- 39822-1410_109f0168-154e-4fc1-8ab2-cd6aeacd87f3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ephedrine hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- XGen Pharmaceuticals DJB, Inc.
- Application
- NDA213536
- Marketing category
- NDA
- Marketing start
- 2021-06-14
- Marketing end
- 0000-00-00
- Substance
- EPHEDRINE HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- alpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 39822-1410-6 | 39822141006 | 10 AMPULE in 1 CARTON (39822-1410-6) > 5 mL in 1 AMPULE (39822-1410-5) | 10 ampule | 2021-11-01 | 0000-00-00 | No | No | Current |